*Holders*
*Notes*
*Class      A*
*Warrants*
*Common      Stock*
*Company*
*Subscription      Agreements*
*Additional      Consideration Warrants*
*Warrants*
*Consent*

|   | i. | the                Notes; |
|--------|----|---------------------------|

|   | ii. | the                Warrants; and |
|--------|-----|----------------------------------|

|   | iii. | the                Consent. |
|--------|------|-----------------------------|

*2008      Financing*
*2008      Offering*
*Securities      Act*
*2008      Notes*
*2008      Warrants*
*Receivables      Financing*

----

|   | (i) | agree                that Item 1 of Schedule 9(p) of the Subscription Agreements, as amended                by                the Consent, which states: “Promissory note financing in the aggregate                principal amount of $5.0 million pursuant to which Axiom Capital                shall                serve as placement agent, which financing may consist of promissory                notes                convertible into shares of the Company’s Common Stock. Said financing is a                lien senior to the liens disclosed on this Schedule 9(p), and senior                to                the qualified financing and related transactions, to which these                disclosure schedules relate.”, is hereby amended, deleted and replaced                with the following: |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

*Axiom      Financing*
*Revolving      Financing*

|   | (ii) | waive                adjustments pursuant to Section 2.1(c)(D) of the Notes which provides                for                adjustments to the Conversion Price of the Notes which would result                from                the consummation of the 2008 Financing and accept an adjustment to                the                Conversion Price (A) in the event that the conversion price of the                2008                Notes is greater than or equal to $0.040 per share, that the Conversion                Price shall be reduced to $0.044 per share, and (B) in the event                that the                conversion price of the 2008 Notes is less than $0.040 per share,                that the                Conversion Price shall be reduced to the price that equals the product                of                the conversion price of the 2008 Notes multiplied by 1.1. |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (iii) | amend                the Notes to extend the maturity date thereof by six                months; |
|--------|-------|--------------------------------------------------------------------------------------------------|

|   | (iv) | waive                adjustments pursuant to Section 3.4 of the Warrants which provides                for                adjustments to the Purchase Price of the Warrants and adjustments                to the                number of shares of Common Stock issuable upon the exercise thereof                which                would result from the consummation of the 2008 Financing and accept                (A) an                adjustment to the Purchase Price (i) in the event that the exercise                price                of the 2008 Warrants equals or exceeds $0.07 per share, the Purchase                Price                shall remain at, or be reduced to, $0.07 per share, and (ii) in the                event                that the exercise price of the 2008 Warrants is, or should become,                less                than $0.07 per share, that the Purchase Price shall be reduced by                an                amount equal to the product of the then exercise price of the 2008                Warrants multiplied by 1.2, and (B) a waiver of the adjustment of                the                number of shares issuable upon exercise of the Warrant as a result                of the                2008 Financing; |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | (v) | agree                that the adjustments to the Conversion Price and Purchase Price,                as well                as the exercise price set forth in the warrants issued as Additional                Consideration (as defined in the Consent) pursuant to the immediately                preceding clauses (i) and (ii) shall not result in further adjustment                to                the Conversion Price or the Purchase Price, except as described                above; |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (vi) | waive                Section 9(q) of the Subscription Agreement to permit the Company                to grant                to the investors rights to immediate registration under the Securities                Act                with respect to the resale of shares of Common Stock issuable upon                conversion of the 2008 Notes or upon exercise of the 2008 Warrants; |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (vii) | waive                Section 11.1(ii) of the Subscription Agreement as a result of which                the                shares of Common Stock issuable upon exercise of the Notes and the                Warrants shall not be included in the registration statements filed                pursuant to rights granted to investors in connection with the 2008                Financing; |
|--------|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (viii) | pursuant                to Section 3(b) and (c) of each of the Collateral Agent Agreements                dated                as of September 28, 2007 and December 20, 2007, respectively, among                the                Company, Axiom Capital Management, Inc., as Collateral Agent and                the other                parties thereto, authorize Axiom Capital Management, Inc., as Collateral                Agent, to subordinate any Collateral (as defined in the Collateral                Agent                Agreement) to the proposed security interest with respect to the                2008                Offering and the Receivables Financing and to enter into any agreement                or                take any action on behalf of the undersigned to effectuate the foregoing                and the 2008 Offering and the Receivables Financing; |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (ix) | waive                Sections 12(a) and (b) of the Subscription Agreements pursuant to                which                the Holders have rights to participate in the 2008 Offering and containing                “favored nations” provisions only with respect to the 2008 Offering and                Receivables Financing; |
|--------|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (x) | amend                Section 11(f) of the Notes to add thereto sentences that reads in                their                entirety as follows: “Each Holder may consent to the amendment to its,                his, or her Notes, without effecting any Notes held by third parties.                All                Notes may be amended by the consent of the Holders of at least 95%                of the                aggregate principal amount of Notes then outstanding.”; |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | (xi) | amend                the Warrants to provide that the Warrants may be amended by the consent                of                the holders of Warrants exercisable for at least 95% of the aggregate                securities issuable upon the exercise thereof;                and |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (xii) | amend                the consent heretofore granted exempting the grant of options and/or                warrants exercisable for up to 4,500,000 shares of Common Stock to                employees and/or consultants of the Company (including any adjustment                to                Conversion Price or Purchase Price resulting upon exercise of said                options                and warrants) to provide that such options and warrants may be subject                to                exercise price anti-dilution protection, but at exercise prices not                lower                than the conversion price of Notes in effect at the time such options                or                warrants are granted and further provided that such options and warrants                shall not under any circumstances be exercisable for Common Stock                in                excess of 10% of the shares of Common Stock of the Company outstanding                immediately following the Axiom Financing (not including any shares                of                Common Stock issued between the effective date of this Waiver and                immediately prior to the closing of the Axiom Financing). |
|--------|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| **TASKER                PRODUCTS CORP.** |
|------------------------------------------|
|                                     |   |
| **By:**                                  |    |
|                                     | Name: |
|                                     | Title:                Chief Executive Officer |

----

**CONSENT      AND AGREEMENT**

*Company*

*Letter*
*Holders*
*Notes*
*Warrants*
*Common      Stock*
*Company*
*Subscription      Agreements*

*Holder*

|  |  ̈ | The                undersigned **CONSENTS                AND AGREES TO**                the matters referenced (i) through (xii) in the                Letter. |
|--|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  |  ̈ | The                undersigned **DOES****NOT****CONSENT AND AGREE**                to                the matters referenced (i) through (xii) in the                Letter. |
|--|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Name:                                                         |                     |
|---------------------------------------------------------------|--------------------------|
|                                                          |                     |
| Address:                                                      |                     |
|                                                          |                     |
| Principal                Amount of                Notes: |      |

----